Correlation between gene mutation status and molecular subtypes
Cervical Squamous Cell Carcinoma (Primary solid tumor)
21 April 2013 | analyses__2013_04_21
Maintainer Information
Citation Information
doi:10.7908/C1PC308S
Maintained by TCGA GDAC Team (Broad Institute/MD Anderson Cancer Center/Harvard Medical School)
Cite as Broad Institute TCGA Genome Data Analysis Center (2013): Cervical Squamous Cell Carcinoma (Primary solid tumor cohort) - 21 April 2013: Correlation between gene mutation status and molecular subtypes. Broad Institute of MIT and Harvard. doi:10.7908/C1PC308S
Overview
Introduction

This pipeline computes the correlation between significantly recurrent gene mutations and molecular subtypes.

Summary

Testing the association between mutation status of 9 genes and 6 molecular subtypes across 39 patients, no significant finding detected with P value < 0.05 and Q value < 0.25.

- No gene mutations related to molecuar subtypes.

Results
Overview of the results

Table 1. Get Full Table Overview of the association between mutation status of 9 genes and 6 molecular subtypes. Shown in the table are P values (Q values). Thresholded by P value < 0.05 and Q value < 0.25, no significant finding detected.

|  | Clinical Features | CN CNMF | METHLYATION CNMF | MRNASEQ CNMF | MRNASEQ CHIERARCHICAL | MIRSEQ CNMF | MIRSEQ CHIERARCHICAL
| nMutated (%) | nWild-Type | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test
PIK3CA | 9 (23%) | 30 | 0.098 (1.00) | 0.358 (1.00) | 0.387 (1.00) | 0.734 (1.00) | 0.88 (1.00) | 0.669 (1.00)
TMCC1 | 4 (10%) | 35 |  | 1 (1.00) | 0.489 (1.00) | 0.0537 (1.00) | 0.628 (1.00) | 0.556 (1.00)
PRG4 | 5 (13%) | 34 | 0.294 (1.00) | 0.83 (1.00) | 0.0205 (1.00) | 0.1 (1.00) | 0.252 (1.00) | 0.302 (1.00)
CDC27 | 5 (13%) | 34 | 0.397 (1.00) | 0.221 (1.00) | 0.128 (1.00) | 0.0681 (1.00) | 0.456 (1.00) | 0.302 (1.00)
NFE2L2 | 6 (15%) | 33 | 0.714 (1.00) | 0.506 (1.00) | 0.584 (1.00) | 0.23 (1.00) | 0.195 (1.00) | 0.308 (1.00)
MAPK1 | 3 (8%) | 36 | 0.141 (1.00) | 1 (1.00) | 0.398 (1.00) | 0.68 (1.00) | 0.0885 (1.00) | 0.556 (1.00)
SSX7 | 3 (8%) | 36 |  | 0.762 (1.00) | 0.24 (1.00) | 0.0517 (1.00) | 0.803 (1.00) | 0.556 (1.00)
UGT3A2 | 3 (8%) | 36 |  | 0.762 (1.00) | 0.0166 (0.83) | 0.0517 (1.00) | 0.55 (1.00) | 0.556 (1.00)
PRB2 | 4 (10%) | 35 |  | 1 (1.00) | 0.489 (1.00) | 0.0537 (1.00) | 0.628 (1.00) | 0.556 (1.00)

Methods & Data
Input

- Mutation data file = CESC-TP.mutsig.cluster.txt

- Molecular subtypes file = CESC-TP.transferedmergedcluster.txt

- Number of patients = 39

- Number of significantly mutated genes = 9

- Number of Molecular subtypes = 6

- Exclude genes that fewer than K tumors have mutations, K = 3

Fisher's exact test

For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

Download Results

This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.

- Analysis Results (MD5 checksum)

- Auxiliary Data (MD5 checksum)

- MAGE-TAB File (MD5 checksum)

References
[1] Fisher, R.A., On the interpretation of chi-square from contingency tables, and the calculation of P, Journal of the Royal Statistical Society 85(1):87-94 (1922)
[2] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)
Copyright © 2013 Broad Institute TCGA GDAC as part of the TCGA Research Network. All rights reserved.
Made with Nozzle